We recently analyzed under homogeneity a large pedigree from Belize with classic juvenile myoclonic epilepsy (JME). After a genome wide search with 146 microsatellites, we obtained significant linkage between chromosome 6p markers, D6S257 and D6S272, and both convulsive and EEG traits of JME. Recomb
Juvenile myoclonic epilepsy: Linkage to chromosome 6p12 in Mexico families
β Scribed by Bai, Dongsheng ;Alonso, Maria E. ;Medina, Marco T. ;Bailey, Julia N. ;Morita, Ryoji ;Cordova, Sergio ;Rasmussen, Astrid ;Ramos-Peek, Jaime ;Ochoa, Adriana ;Jara, Aurelio ;Donnadieu, Francisco R. ;Cadena, Gilbert ;Yamakawa, Kazuhiro ;Delgado-Escueta, Antonio V.
- Publisher
- John Wiley and Sons
- Year
- 2002
- Tongue
- English
- Weight
- 134 KB
- Volume
- 113
- Category
- Article
- ISSN
- 0148-7299
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
Juvenile myoclonic epilepsy is a common subtype of idiopathic epilepsy accounting for 4β11% of all epilepsies. We reported previously significant evidence of linkage between chromosome 6p12β11 microsatellites and the clinical epilepsy and EEG traits of JME families from Belize and Los Angeles. To narrow the JME region, we ascertained and genotyped 31 new JME families from Mexico using a later generation of GΓ©nΓ©thon microsatellites. Two point linkage analyses obtained significant Z~max~ values of 3.70 for D6S1573 and 2.65 for D6S1714 at ΞΈ~mβ=βf~β=β0.10, and 3.49 for D6S465, 2.11 for D6S1960 at ΞΈ~mβ=βf~β=β0.05 assuming autosomal dominant inheritance with 70% ageβdependent penetrance. Multipoint LOD score curve peaked at 4.21 for D6S1573. Haplotype and recombination analysis reduced the JME region to 3.5 cM flanked by D6S272 and D6S1573. These results provide confirmatory evidence that a major susceptibility gene for JME exists in chromosome 6p12 in SpanishβAmerinds of Mexico. Β© 2002 WileyβLiss, Inc.
π SIMILAR VOLUMES
Malignant melanoma occurs as a familial cancer in 5%-109/ 0 of cases, where it segregates in a manner consistent with autosomal dominant inheritance. Evidence from cytogenetics, fine mapping studies of deletions in melanomas and recent linkage studies supports the location of a human melanoma predis